While others played safe, Shanghvi bet on complex generics and specialty pharma, and rode a wave of acquisitions to make Sun ...

Dilip Shanghvi is not one for flamboyant statements or headline-grabbing moves. Yet, over the decades, the soft-spoken Chairman & Managing Director of Sun Pharma has turned the company from a ...

In this week's newsletter, also read about how 81-year-old Meena Bindra built a fashion empire with BIBA, Raamdeo Agrawal's ...

who is Dilip Shanghvi’s son. Some analysts see Sun Pharma’s growth to be driven by a mix of specialty, ROW and India markets. “We see the company delivering 8-10 per cent revenue growth on a ...

4.5 lakh crore. She’s also known as the daughter-in-law of Dilip Shanghvi, the founder and managing director of Sun Pharma, who is India’s wealthiest figure in the healthcare industry.

This father-son duo’s pharma company is taking on the likes of Sun Pharma, Abbot Bhavya Kaushal 15 inspiring quotes by Dilip Shanghvi, the man who built India's most valuable pharma company ...

Sun Pharma chairman and managing director Dilip Shanghvi said: "Combining Unloxcyt…with Sun Pharma's global presence means patients with cSCC may soon have access to an important, new treatment ...

Dilip Shanghvi had said in February that the judgment was crucial for Sun Pharma's future course of action on this drug launch. "...the judgment is to validate the existing judgment, and we can't ...

“Over the years, with Sun Pharma’s strategic interventions, Taro has remained a key player in the generic dermatology market in a challenging environment,” said Dilip Shanghvi, the Indian ...

Dilip Shanghvi had said in February that the judgment was crucial for Sun Pharma's future course of action on this drug launch. Checkpoint is a commercial-stage company that develops novel ...